Medical Second Opinion Market is expected to reach US$ 10,739.48 Mn by 2027

Medical Second Opinion Market for Orthopedic Diseases to Grow at Fastest CAGR during Forecast Period

According to our new market research study on “Medical Second Opinion Market to 2027 – Global Analysis and Forecast – by Disorder and Service Provider,” the market is expected to reach US$ 10,739.48 million in 2027 from US$ 3,204.57 million in 2019; it is estimated to grow at a CAGR of 16.8% from 2020 to 2027. The report highlights trends prevailing in the global medical second opinion market and the drivers and restraints pertaining to the market growth.

Based on disorder, the global medical second opinion market is segmented into cancer, orthopedic disorders, cardiac disorders, neurological disorders, nephrological disorders, hematologic blood disorders, chronic obstructive pulmonary diseases (COPD), organ transplants, and other diseases. The cancer segment held the largest share of the market in 2019. However, orthopedic disorders segment is estimated to register the highest CAGR in the market during the forecast period. Increasing prevalence of orthopedic conditions, and growing focus on improving accuracy of diagnosis and treatment are the factors boosting the market for the orthopedic disorder segment.

The global medical second opinion market growth is mainly attributed to factors such as increasing prevalence of chronic diseases, growing emphasis on superior treatment outcomes, and rising preference for healthcare cost optimization. However, the lack of awareness and reluctance toward opting for medical second opinion in emerging nations hinders the growth of the market.

Medisense Healthcare Solutions Pvt. Ltd.; Second Opinion International; Elite Medical Services; Cigna; Helsana; WorldCare; Vidal Health Insurance TPA Pvt Ltd; Medix; 2nd.MD; AXA, Teladoc Health, Inc; DoctorSpring Pvt. Ltd; USARAD Holdings Inc (SecondOpinions.com); Cleveland Clinic; Grand Rounds, Inc.; Mass General Brigham Incorporated. (Partners Healthcare); and Stanford Health Care are among the leading companies operating in the medical second opinion market.

Global Medical Second Opinion Market, By Region, 2019 (%)

---

Medical Second Opinion Market to Grow at a CAGR of 16.8% to reach US$ 10,739.48 Million from 2019 to 2027

Download Free Sample

---

Medical Second Opinion Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Disorder (Cancer, Orthopedic Disorders, Cardiac Disorders, Neurological Disorders, Nephrological Disorders, Hematologic Blood Disorders, COPD, Organ Transplants, and Other Diseases); Service Providers (Hospitals, Health Insurance Companies, and Online Services); and Geography

The report segments global medical second opinion market as follows:

By Disorders

• Cancer
• Orthopaedic Disorders
• Cardiac Disorders
• Neurological Disorders
• Nephrological Disorders
• Hematologic Blood Disorders
• Chronic Obstructive Pulmonary Diseases (COPD)
• Organ Transplants
• Other Disorders

By Service Providers

• Hospitals
• Health Insurance Companies
• Online Services

By Geography

• North America
  • • US
    • Canada
    • Mexico
• Europe
  • • France
    • Germany
    • UK
    • Spain
    • Italy
• Asia Pacific (APAC)
  • • China
    • India
    • Japan
    • Australia
    • South Korea
• Middle East and Africa (MEA)
  • • Saudi Arabia
    • UAE
    • South Africa
• South and Central America (SCAM)
  • • Brazil
    • Argentina

Contact Us

Phone: +1-646-491-9876

Email Id: sales@theinsightpartners.com